Golimumab-associated persistent erythema multiforme in a patient with ulcerative colitis in full remission

We report herein a 41-year-old woman with persistent erythema multiforme, that occurred 18 months after onset of golimumab treatment of her ulcerative colitis; the latter remains in full remission over a period of 36 months.
Source: Dermatology Online Journal - Category: Dermatology Source Type: research